lobbying_activities: 127630

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
127630	8d199abc-b2fd-4ba6-ab6c-60452c1cfdce	YY	ZUCKERMAN SPAEDER LLP	42160	ANDRX PHARMACEUTICALS INC	2001	year_end	MED	Food & Drug Administration authorization of generic version of Tiazac and Prilosec; policy issues concerning generic drugs.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE			0	0	2002-02-04T00:00:00-05:00